April 23, 1999
AMERIPATH, INC. ANNOUNCES AGREEMENT TO PROVIDE PATHOLOGY SERVICES TO BLUE CROSS AND BLUE SHIELD OF FLORIDA

Riviera Beach, FL, April 23, 1999 - AmeriPath, Inc. (Nasdaq: PATH), a physician group practice focused on anatomic pathology services, continues to enhance its regional business model in Florida. Today it announced an agreement with Blue Cross and Blue Shield of Florida to provide anatomic pathology diagnostic services to members and enrollees of the insurer's HMO, PPS, and PPC products.

AmeriPath employs 67 pathologists and 13 dermatopathologists in its Florida operations, who provide diagnostic pathology services to dermatologists, hematologists/oncologists, urologists, ob/gyns, as well as inpatient hospitals, surgery centers, and others in the medical community.

The Letter of Agreement, which was effected on April 21, 1999, is for a three-year term which covers all of AmeriPath's 11 practices and six laboratories in Florida and represents the Company's ongoing commitment to developing and maintaining long-term relationships with its managed care partners.

"We are pleased to enter into this contract with Blue Cross of Blue Shield of Florida as a network participant, and are committed to providing our high level of quality diagnostic services to its members and physicians," said James C. New, President and CEO of AmeriPath, Inc. "This is a very important contract to AmeriPath as we continue our development as the leading statewide provider of anatomic pathology services."

"We are delighted that AmeriPath will continue its participation in our provider networks," stated Daniel Lestage, M.D., Blue Cross and Blue Shield of Florida's Vice President for Professional Relations and Quality Compliance. "Blue Cross and Blue Shield of Florida continues to develop relationships with quality providers of medical services."

AmeriPath, Inc. is the nation's leading physician group practice focused on providing anatomic pathology services to physicians, hospitals, national clinical laboratories and managed care organizations. The Company presently operates in ten states and employs 231 pathologists who provide medical services through outpatient pathology laboratories, hospital inpatient laboratories and outpatient surgery centers.

.......................................................................................................................

This release contains certain forward-looking statements regarding AmeriPath, including its operations and prospects. Past performance is not necessarily indicative of future results. In addition, AmeriPath's actual results could differ materially from the results anticipated in these forward-looking statements as a result of uncertainties, including risks relating to demand, pricing, government regulation, payments and reimbursement, changes on reimbursement coding guidelines, dependence upon contracts and pathologists, acquisitions, integration of acquired practices, the market for pathology services, competition, and other factors identified in AmeriPath's filings with the Securities and Exchange Commission.